Funds holding LEXARIA BIOSCIENCE CORP
ISIN US52886N4060 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 351.6K $
- Share of capital
- 2.6 % of 24.8M shares on Jul 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 298,436 | 167.1K $ | 0.00 % | 1.20 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 171,896 | 103.5K $ | 0.00 % | 0.69 % | as of May 31, 2026 ↗ |
| Invenomic Fund NORTHERN LIGHTS FUND TRUST II | 99,986 | 39.1K $ | 0.00 % | 0.40 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 31,892 | 19.2K $ | 0.13 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 26,138 | 15.7K $ | 0.11 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,622 | 7K $ | 0.05 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invenomic Fund NORTHERN LIGHTS FUND TRUST II | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 639,970 | +8.2 % |
| 2026Q2 | 6 | 0 | 591,263 | +19.3 % |
| 2026Q1 | 6 | 0 | 495,762 | -5.3 % |
| 2025Q4 | 6 | 0 | 523,277 | +5.2 % |
| 2025Q3 | 6 | 0 | 497,454 | -7.7 % |
| 2025Q2 | 6 | 0 | 538,881 | +19.6 % |
| 2025Q1 | 6 | 0 | 450,665 | +11.0 % |
| 2024Q4 | 6 | 0 | 405,946 | -9.5 % |
| 2024Q3 | 6 | +1 | 448,628 | +13.2 % |
| 2024Q2 | 5 | 0 | 396,367 | -35.9 % |
| 2024Q1 | 5 | 0 | 617,947 | -16.0 % |
| 2023Q4 | 5 | 736,075 |
Institutional managers
25 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Invenomic Capital Management LP | 442,301 | 345K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 294,157 | 229.5K $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 140,013 | 109.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 52,708 | 41.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 39,301 | 30.7K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 27,445 | 21.4K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 25,067 | 19.6K $ | as of Mar 31, 2026 |
| Vontobel Holding Ltd. | 23,000 | 17.9K $ | as of Mar 31, 2026 |
| Krilogy Financial LLC | 19,653 | 19.4K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 18,465 | 14 $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 18,389 | 14.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 16,300 | 12.7K $ | as of Mar 31, 2026 |
| BANK OF MONTREAL /CAN/ | 14,033 | 10.9K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 13,513 | 10.5K $ | as of Mar 31, 2026 |
| BCV Asset Management Inc. | 10,000 | 7.8K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 7,140 | 6K $ | as of Mar 31, 2026 |
| Byrne Asset Management LLC | 800 | 624 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 605 | 471 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 489 | 381 $ | as of Mar 31, 2026 |
| Federation des caisses Desjardins du Quebec | 382 | 298 $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 166 | 144 $ | as of Mar 31, 2026 |
| GABLES CAPITAL MANAGEMENT INC. | 13 | 10 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3 | 2 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2 | 2 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 1 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding LEXARIA BIOSCIENCE CORP". https://titelia.com/en/stocks/lexaria-bioscience-corp-US52886N4060